ADPHC Launches Region’s First Personalized Weight Management Programme in Collaboration with DoH

ADPHC

Abu Dhabi Public Health Centre (ADPHC), in collaboration with the Department of Health – Abu Dhabi (DoH), has launched the region’s first-of-its-kind Personalized Weight Management Programme.

Integrating digital monitoring, a unique reimbursement model and tailored clinical support, this initiative promotes sustainable weight management and active living to significantly reduce the risks of chronic diseases such as type 2 diabetes, heart disease, and certain cancers, and ultimately, enhancing overall quality of life and health longevity.

Open to eligible Thiqa members aged 18 and above who are clinically identified as overweight or obese, the programme features an innovative reimbursement model designed to encourage sustained engagement, accountability, and continuous active participation.

Dr. Noura Al Ghaithi, Undersecretary of DoH, said, “Our focus is on health – not just weight. This programme supports our vision for an active, health-conscious community, empowering individuals through personalized and science-driven solutions. Weight management requires tailored solutions, not a ‘one-size-fits-all’ approach, and this programme ensures each participant receives precisely what they need to succeed.”

Dr. Rashid Obaid Al Suwaidi, Director-General of ADPHC, stated, “We know that even moderate weight loss and modest increases in physical activity significantly lower chronic disease risk. Traditionally, healthcare systems have lacked clear pathways for doctors to support patients in becoming physically active or to effectively link them with supportive services. Our programme directly addresses this gap by providing structured guidance, personalized activity plans, and continuous monitoring support through digital tools and clinical oversight – empowering our community to proactively manage their health and enhance their quality of life.”

Also Read: Sanofi and DoH Forge Strategic Alliance.

Commenting on the announcement, Tala Mokdad, Associate VP Corporate Affairs, Lilly Middle East and Türkiye (META), stated: “Abu Dhabi is setting the gold standard for access to obesity treatment, and the global community should take notice. Countries have an opportunity to modernize existing models by embracing science-backed treatments that drive meaningful progress. Lilly is committed to turning scientific innovation into real-world-impact- ensuring that no patient is left behind. But without bold, policy-driven access, millions will remain trapped in a cycle of preventable disease. Abu Dhabi’s leadership is a powerful example of what’s possible for patients when bold vision is matched by decisive action.”

SHARE
TWEET
SHARE
PIN
Receive the latest news

Subscribe To Our Newsletter

Get notified about new articles